Table 4 GP’s reason, management, and satisfaction on tele-ECG consulting
Variables | Normal ECG (n = 253) | Abnormal ECG (n = 252) | Total (n = 505) | p-value |
|---|---|---|---|---|
GP’s reason for tele-ECG: | ||||
Manifested CVD symptoms | 76 (30.0) | 116 (46.0) | 192 (38.0) | < 0.001 |
Unable to interpret the ECG | 2 (0.8) | 12 (4.8) | 14 (2.8) | 0.007 |
Ask for an expert opinion | 175 (69.2) | 121 (48.0) | 296 (58.6) | < 0.001 |
Othersa | 0 (0.0) | 3 (1.2) | 3 (0.6) | 0.124 |
Management after tele-ECG: | ||||
Refer to hospital | 0 (0.0) | 88 (34.9) | 88 (17.4) | < 0.001 |
Outpatient without medications | 183 (72.3) | 80 (31.7) | 263 (52.1) | < 0.001 |
Outpatient with new or continued medications | 70 (27.7) | 84 (33.3) | 154 (30.5) | 0.167 |
Medications at primary care following tele-ECG consultation: | ||||
Aspirin | 2 (0.8) | 49 (19.4) | 51 (10.1) | < 0.001 |
Clopidogrela | 0 (0.0) | 8 (3.2) | 8 (1.6) | 0.004 |
Beta blockera | 0 (0.0) | 8 (3.2) | 8 (1.6) | 0.004 |
Calcium-channel blocker | 53 (20.9) | 95 (37.7) | 148 (29.3) | < 0.001 |
ACE inhibitor | 7 (2.8) | 54 (21.4) | 61 (12.1) | < 0.001 |
Angiotensin receptor blocker | 4 (1.6) | 10 (4.0) | 14 (2.8) | 0.102 |
Diuretic | 0 (0.0) | 17 (6.7) | 17 (3.4) | < 0.001 |
Nitrate | 13 (5.1) | 47 (18.7) | 60 (11.9) | < 0.001 |
Lipid-lowering agents | 8 (3.2) | 39 (15.5) | 47 (9.3) | < 0.001 |
GP’s satisfaction on tele-ECG: | ||||
Yes | 232 (91.7) | 247 (98.0) | 479 (94.9) | 0.001 |